Blood Transfusion Threshold for Cardiac Surgery

Evidence-Based Threshold for Cardiac Surgery

The American Society of Anesthesiologists recommends a restrictive transfusion strategy with a hemoglobin threshold of 7.5-8.0 g/dL for postoperative cardiac surgery patients to reduce red blood cell use without increasing morbidity or mortality 1, 2
Three large-scale randomized controlled trials involving over 8,800 patients demonstrated no significant difference in 30-day mortality between restrictive and liberal transfusion strategies, with a strength of evidence graded as high 1, 2
Meta-analyses showed the non-inferiority of restrictive strategies persisted at 6-month mortality, with moderate certainty evidence 1
No increase in adverse events, including myocardial infarction, arrhythmias, stroke, acute renal failure, or infections, was found between the two strategies, based on high-quality evidence 1, 2
A significant reduction in red blood cell units transfused per patient was observed with the restrictive approach, with a high strength of evidence 1, 2

A 6.0 g/dL threshold is recommended for patients on cardiopulmonary bypass with moderate hypothermia, based on evidence from a randomized controlled trial 3
A 7.0 g/dL threshold is recommended for patients at risk of critical end-organ ischemia, with a moderate strength of evidence 3

The American College of Cardiology recommends assessing hemoglobin level postoperatively and transfusing if Hb < 7.5 g/dL, with a high strength of evidence 1, 2
If Hb 7.5-8.0 g/dL, consider patient-specific factors, such as presence of ongoing bleeding, signs of organ ischemia, hemodynamic instability, and adequacy of cardiopulmonary reserve, based on moderate certainty evidence 1, 2, 4, 3

Patients with preexisting coronary artery disease may warrant transfusion at the higher end of the 7.5-8.0 g/dL range, but meta-analyses found no significant difference in mortality or acute coronary syndrome between restrictive and liberal strategies, with a high strength of evidence 1, 2
Patients with acute coronary syndrome should avoid liberal transfusion strategies, as they are associated with increased mortality, and transfusion may be beneficial when Hb falls below 8.0 g/dL, based on moderate certainty evidence 2, 4, 5

Do not base transfusion decisions solely on hemoglobin concentration, as this may lead to unnecessary transfusions, with a high strength of evidence 1
Do not transfuse multiple units without reassessment, as single-unit transfusions followed by clinical and laboratory reassessment reduce unnecessary blood product exposure, based on moderate certainty evidence 5, 6
Do not use liberal thresholds routinely, as they provide no mortality benefit and significantly increase blood product utilization, with a high strength of evidence 1, 2

The recommendation carries GRADE 1+ evidence with strong agreement from expert consensus, based on multiple large randomized controlled trials and high-quality meta-analyses 1, 2

Target post-transfusion hemoglobin of 7.5-9.0 g/dL in most cardiac surgery patients, as higher targets have not demonstrated additional benefit, with a moderate strength of evidence 8, 6